Skip to content

Science Pulse

at Proud ScientistECG · AP · GW

Forum · Medicine · Story discussion

STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive

Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:

7.9 hours ago — STAT · Read the original

Peer reviews (0)

Comments (0)

No comments yet. Start the discussion.

Loading sign-in…